- Report
- April 2024
- 202 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- April 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 151 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- April 2025
- 400 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- September 2021
- 589 Pages
Global
From €3822EUR$4,200USD£3,277GBP
€5461EUR$6,000USD£4,681GBP
- Report
- January 2024
- 92 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Pelvic Organ Prolapse Devices market is a segment of the Medical Devices industry that focuses on the development and sale of products used to treat pelvic organ prolapse (POP). POP is a condition in which the pelvic organs, such as the bladder, uterus, and rectum, drop from their normal position and press against the walls of the vagina. Pelvic Organ Prolapse Devices are designed to provide support to the pelvic organs and reduce the symptoms of POP. These devices include pessaries, which are inserted into the vagina to provide support, and surgical meshes, which are used to reinforce the weakened pelvic floor muscles.
Some companies in the Pelvic Organ Prolapse Devices market include Boston Scientific, Coloplast, Cook Medical, Ethicon, and Medtronic. Show Less Read more